XVIVO Q3 Net Profit Rises Year-on-Year to SEK 44.62 Million

Bitget2026/10/22 05:38

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Xvivo Perfusion’s third-quarter 2026 net profit rose year-on-year to SEK 44.6 million.
Net sales climbed 34% year-on-year to SEK 252.6 million.
Operating cash flow more than doubled year-on-year to SEK 53 million, supported by increased sales.
XVIVO Heart Assist Transport received CE certification during the quarter, making the technology commercially available across Europe.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xvivo Perfusion AB published the original content used to generate this news brief on October 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

XVIVO Q3 Net Profit Rises Year-on-Year to SEK 44.62 Million

You may also like

Crypto prices